Display options
Cite
Lee HY, Lee SH, Xu C, et al. Synthesis and characterization of PVP-coated large core iron oxide nanoparticles as an MRI contrast agent. Nanotechnology. 2008;19(16):165101doi: 10.1088/0957-4484/19/16/165101.
Lee, H. Y., Lee, S. H., Xu, C., Xie, J., Lee, J. H., Wu, B., Koh, A. L., Wang, X., Sinclair, R., Wang, S. X., Nishimura, D. G., Biswal, S., Sun, S., Cho, S. H., & Chen, X. (2008). Synthesis and characterization of PVP-coated large core iron oxide nanoparticles as an MRI contrast agent. Nanotechnology, 19(16), 165101. https://doi.org/10.1088/0957-4484/19/16/165101
Lee, Ha-Young, et al. "Synthesis and characterization of PVP-coated large core iron oxide nanoparticles as an MRI contrast agent." Nanotechnology vol. 19,16 (2008): 165101. doi: https://doi.org/10.1088/0957-4484/19/16/165101
Lee HY, Lee SH, Xu C, Xie J, Lee JH, Wu B, Koh AL, Wang X, Sinclair R, Wang SX, Nishimura DG, Biswal S, Sun S, Cho SH, Chen X. Synthesis and characterization of PVP-coated large core iron oxide nanoparticles as an MRI contrast agent. Nanotechnology. 2008 Apr;19(16):165101. doi: 10.1088/0957-4484/19/16/165101. PMID: 21394237; PMCID: PMC3050625.
Copy Download .nbib Format: NLM
Share it on

Nanotechnology. 2008 Apr;19(16):165101. doi: 10.1088/0957-4484/19/16/165101.

Synthesis and characterization of PVP-coated large core iron oxide nanoparticles as an MRI contrast agent.

Nanotechnology

Ha-Young Lee, Sang-Hoon Lee, Chenjie Xu, Jin Xie, Jin-Hyung Lee, Bing Wu, Ai Leen Koh, Xiaoying Wang, Robert Sinclair, Shan X Wang, Dwight G Nishimura, Sandip Biswal, Shouheng Sun, Sun Hang Cho, Xiaoyuan Chen

Affiliations

  1. Molecular Imaging Program at Stanford (MIPS) and Bio-X Department of Radiology, Stanford University, 1201 Welch Rd P095, Stanford, CA 94305-5484, USA.

PMID: 21394237 PMCID: PMC3050625 DOI: 10.1088/0957-4484/19/16/165101

Abstract

The purpose of this study was to synthesize biocompatible polyvinylpyrrolidone (PVP)-coated iron oxide (PVP-IO) nanoparticles and to evaluate their efficacy as a magnetic resonance imaging (MRI) contrast agent. The PVP-IO nanoparticles were synthesized by a thermal decomposition method and characterized by x-ray diffraction (XRD), transmission electron microscopy (TEM), dynamic light scattering (DLS), and a superconducting quantum interface device (SQUID). The core size of the particles is about 8-10 nm and the overall size is around 20-30 nm. The measured r(2) (reciprocal of T(2) relaxation time) and r2∗ (reciprocal of T2∗ relaxation time) are 141.2 and 338.1 (s mM)(-1), respectively. The particles are highly soluble and stable in various buffers and in serum. The macrophage uptake of PVP-IO is comparable to that of Feridex as measured by a Prussian blue iron stain and phantom study. The signal intensity of a rabbit liver was effectively reduced after intravenous administration of PVP-IO. Therefore PVP-IO nanoparticles are potentially useful for T(2)-weighted MR imaging.

References

  1. Radiology. 1988 Aug;168(2):297-301 - PubMed
  2. Radiology. 1995 May;195(2):489-96 - PubMed
  3. Radiology. 2002 Dec;225(3):808-14 - PubMed
  4. Radiology. 2004 Oct;233(1):101-12 - PubMed
  5. J Magn Reson Imaging. 2006 Sep;24(3):657-66 - PubMed
  6. Magn Reson Imaging. 1995;13(5):661-74 - PubMed
  7. J Biomed Mater Res B Appl Biomater. 2006 Oct;79(1):142-50 - PubMed
  8. J Control Release. 2004 Sep 14;99(1):83-101 - PubMed
  9. J Am Chem Soc. 2005 Apr 27;127(16):5732-3 - PubMed
  10. Biomaterials. 2005 Mar;26(7):729-38 - PubMed
  11. Invest Radiol. 2004 Jan;39(1):56-63 - PubMed
  12. Cancer Res. 2006 Jan 15;66(2):605-12 - PubMed
  13. Radiology. 1998 Dec;209(3):831-6 - PubMed

Publication Types

Grant support